Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Name | TYRO3 over exp |
| Gene Variant Detail | |
| Relevant Treatment Approaches |
| Molecular Profile | Indication/Tumor Type | Response Type | Relevant Treatment Approaches | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|---|
| TYRO3 over exp | Advanced Solid Tumor | sensitive | RXDX-106 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, RXDX-106 inhibited Tam-family kinases activity in transformed cells overexpressing Tyro3 in culture, resulting in tumor growth inhibition in cell line xenograft models (Eur J Cancer, Vol 69, Supplement 1, December 2016, Page S31). | detail... |